Ercros 

0
112
+$0.00+0% 00:00 今天

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
0
股息殖利率
-
股息
-

股息

0%股息殖利率
Jul 24
$0.10
Jun 23
$0.16
Jun 22
$0.09
Jun 20
$0.06
Jun 19
$0.07
10年成長
不適用
5年成長
不適用
3年成長
不適用
1年成長
不適用

財報

28Jul預期
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
999
333
-333
-999
預期EPS
不適用
實際EPS
不適用

財務

-1.69%利潤率
未盈利
2019
2020
2021
2022
2023
2024
750.87M營收
-12.72M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 ECRBF 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Ercros, S.A. is a Spanish industrial group primarily engaged in the production and distribution of basic chemicals, intermediate chemical products, and pharmaceuticals. The company also extends its market reach through export activities. Its diverse operations are structured into three main divisions: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment manufactures a broad spectrum of products, including ammonia, bioplastics, various caustic solutions (potash and soda), chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers. These compounds serve as vital industrial intermediates, essential for applications such as purifying drinking and wastewater, maintaining swimming pools, bleaching paper and textiles, and formulating detergents, solvents, and strippers. They also find use in producing printing inks, animal feed, and cooling equipment. The Intermediate Chemicals division supplies products like formaldehyde, various glues and resins, molding powders, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate. These are crucial for manufacturing wood-based panels like chipboards, decorative laminates, and plywoods, as well as resins, paints, and varnishes for the furniture and decoration sectors. Furthermore, they are integral to producing electrical components such as plugs and switches, and contribute to household, sanitary, and packaging materials within the textile tanning industry. Ercros's Pharmacy segment focuses on developing and producing active pharmaceutical ingredients (APIs) and intermediate compounds. Its portfolio includes agents for various therapeutic areas, such as bacterial infections (e.g., azithromycin, clarithromycin, erythromycins, calcium and sodium fosfomycin, fosfomycin trometamol, fusidic acid), high cholesterol (amlodipine besylate), ulcers (famotidine), and fungal infections. With a rich history, Ercros, S.A. was established in 1817 and maintains its corporate headquarters in Barcelona, Spain.
Show more...
執行長
Antonio Zabalza Marti
員工
1346
國家
西班牙
ISIN
ES0125140A14
WKN
000A0YBXV

上市

0 Comments

分享你的想法

FAQ

Ercros 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,Ercros 的股票以代號 ECRBF 進行交易。
Ercros 去年的營收是多少?
Ercros 去年的營收為 750.87MUSD。
Ercros 去年的淨利是多少?
ECRBF 去年的淨收益為 -12.72MUSD。
Ercros 會發放股息嗎?
是的,ECRBF 的股息每 年度 發放一次。每股最新股息為 0.1 USD。截至今日,股息殖利率(FWD)% 為 0%。
Ercros 有多少名員工?
截至 September 05, 2026,公司共有 1,346 名員工。
Ercros 位於哪個產業?
Ercros從事於Other產業。
Ercros 何時完成拆股?
Ercros 最近沒有進行任何拆股。
Ercros 的總部在哪裡?
Ercros 的總部位於 西班牙 的 Barcelona。